- Home
- VOR vs MRCC Comparison
VOR vs MRCC Comparison
Compare VOR & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- MRCC
- Stock Information
- Founded
- VOR 2015
- MRCC 2011
- Country
- VOR United States
- MRCC United States
- Employees
- VOR N/A
- MRCC N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- MRCC Investment Managers
- Sector
- VOR Health Care
- MRCC Finance
- Exchange
- VOR Nasdaq
- MRCC Nasdaq
- Market Cap
- VOR 202.4M
- MRCC 176.4M
- IPO Year
- VOR 2021
- MRCC 2012
- Fundamental
- Price
- VOR $2.42
- MRCC $6.40
- Analyst Decision
- VOR Buy
- MRCC Hold
- Analyst Count
- VOR 7
- MRCC 1
- Target Price
- VOR $3.77
- MRCC $8.00
- AVG Volume (30 Days)
- VOR 47.5M
- MRCC 84.9K
- Earning Date
- VOR 08-07-2025
- MRCC 08-06-2025
- Dividend Yield
- VOR N/A
- MRCC 15.75%
- EPS Growth
- VOR N/A
- MRCC 3301.50
- EPS
- VOR N/A
- MRCC 0.32
- Revenue
- VOR N/A
- MRCC $56,983,000.00
- Revenue This Year
- VOR N/A
- MRCC N/A
- Revenue Next Year
- VOR N/A
- MRCC N/A
- P/E Ratio
- VOR N/A
- MRCC $19.54
- Revenue Growth
- VOR N/A
- MRCC N/A
- 52 Week Low
- VOR $0.13
- MRCC $6.11
- 52 Week High
- VOR $3.29
- MRCC $8.85
- Technical
- Relative Strength Index (RSI)
- VOR 73.52
- MRCC 48.93
- Support Level
- VOR $2.25
- MRCC $6.32
- Resistance Level
- VOR $2.84
- MRCC $6.50
- Average True Range (ATR)
- VOR 0.54
- MRCC 0.16
- MACD
- VOR 0.10
- MRCC 0.01
- Stochastic Oscillator
- VOR 70.92
- MRCC 47.92
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.